Data Characteristics
Stem cell therapy clinical trial data originates from global clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP), academic journals, conference papers, and pharmaceutical company R&D reports. Update frequencies vary; registry data updates when trial statuses change, while journal data updates with publication cycles. Document structures are primarily semi-structured and unstructured, including Protocols, Investigator's Brochures, Informed Consent Forms, and trial results reports. Core fields include NCT ID, stem cell type (e.g., MSC, HSC), disease indication (e.g., Crohn's disease, spinal cord injury), administration route (e.g., intravenous, intrathecal), dosage (e.g., cells/kg), dosing frequency, follow-up period (e.g., weeks, months), and primary and secondary outcome measures. Dosage units often include cells/kg, cells/cm², or total cells. Follow-up time units are typically days, weeks, or months.
Constraints on Model Integration and Configuration
The semi-structured and unstructured nature of stem cell therapy clinical trial data requires robust text parsing and entity recognition capabilities during data preprocessing. The variety of stem cell types, disease indications, and complex dosing regimens necessitate precise identification and semantic relationship mapping between different fields. Inconsistent data update frequencies require an incremental update strategy for the knowledge base to ensure the model always uses the latest information for pre-screening. For example, new trial results might change the risk assessment of existing stem cell therapies. Additionally, diverse measurement units and follow-up periods challenge the model's robustness in handling numerical and time-series data, requiring special attention to unit standardization and dimension conversion during configuration. Multilingual sources (e.g., data from some non-English registries) may also require multilingual processing capabilities or additional translation preprocessing steps.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 800–1200 characters (characters) | Balances semantic completeness of long texts with model processing efficiency, preventing truncation of key information. |
Recall count (Recall Count) | Top 15 entries (top 15) | Ensures coverage of multiple highly relevant trial records, increasing pre-screening accuracy. |
Similarity threshold (Similarity Threshold) | 0.78 | Balances recall and precision, filtering out trials with low semantic relevance. This value requires calibration against actual data. |
Rerank result count (Rerank Return Count) | 5 entries (5 items) | Selects the most relevant few results for further evaluation, reducing the manual screening burden. |
PARSE_FILE_TIMEOUT_SECONDS | 300 seconds (seconds) | Accommodates parsing time for large trial protocol documents, preventing data ingestion failures due to timeouts. |
maxContext | 4096 | Adapts to detailed background information and complex descriptions within trial protocols, ensuring the model can process the complete context. |
Common Pitfalls
- Stem cell type or disease indication fields are empty in model results: This occurs if entities are not correctly identified or extracted during document parsing, or if the knowledge base lacks necessary entity mapping rules.
- Pre-screening results do not match expectations, with many irrelevant trials recalled: This happens if the semantic similarity threshold is set too low, failing to effectively filter out low-relevance text segments.
- After integrating an external clinical trial registry API, new data is not retrieved or data formats do not match: This indicates incorrect API authentication configuration or incompatibility between the returned data structure and preset parsing rules.
Verification Steps
- Choose queries with known specific stem cell types and disease indications. Check if the returned results include all relevant and important clinical trial records. Verify the accuracy of key fields (e.g.,
stem cell type,indication,administration route). - Select a batch of complex queries. Evaluate the top
Rerank result count(Rerank Return Count) results returned by the model. Verify if their relevance ranking aligns with the query intent and if there are any clearly irrelevant distractions. - Simulate external system data updates. Observe if the knowledge base promptly synchronizes the latest trial information. Randomly select some newly added data and confirm it can be correctly recalled and understood by the model through queries.
The values provided are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.